Isomab

Professor Bill Sessa, formerly Chief Scientific Officer of Internal Medicine at Pfizer, has been appointed Chair of Isomab's Scientific Advisory Board. The move gives the biotech company a senior figure with decades of large-pharma experience as it advances its scientific programmes, and the announcement was distributed via PR Newswire.